genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
Expand submenu
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
>
Multimedia
>
Podcasts
>
G. Steven Burrill, CEO of Burrill & Company.
G. Steven Burrill, CEO of Burrill & Company.
April 6, 2006
/wp-content/uploads/2018/09/gc_24.mp3
Podcasts
Resources
Research and development
Research resources
Also of Interest
Lilly's GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm
Centrix and University of Sussex Collaborate to Drive Data-Driven Pharma Development
StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too
BMS Chooses Houston for $2.3B Manufacturing Facility
Onshoring Is Here. The Hiring Wave Is Still a Decade Out
Related Media
Celebrating DNA: Matthew Cobb's Reflections on the Double Helix
The Sun Sets on AGBT: A Report from the Last Day
Reporter's Notebook: Opening Day at the J.P. Morgan Healthcare Conference
Moving the Drug Pipeline Forward with Mechanistic Modeling
GENcast: Reducing Drug Discovery and Development Risk with Mechanistic Modeling
Shehnaaz Suliman, MD, MPhil, Discusses Targeted Respiratory Therapies on "Close to the Edge"
